GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes
Authors:
Open Access
- 30 August 2023
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 49 (5) , 101470
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Evidence for altered transport of insulin across the blood–brain barrier in insulin-resistant humansActa Diabetologica, 2013
- Molecular links between Alzheimer’s disease and diabetes mellitusNeuroscience, 2013
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseasesJournal of Endocrinology, 2013
- Exenatide and the treatment of patients with Parkinson’s diseaseJournal of Clinical Investigation, 2013
- Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s diseaseNeurochemistry International, 2013
- Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7‐year follow‐up studyJournal of Internal Medicine, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009
- Amyloid beta oligomers induce impairment of neuronal insulin receptorsThe FASEB Journal, 2007
- Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brainsActa Neuropathologica, 2003